Galectin Therapeutics | GALT - Passifs Courants

Prix De L'Action
3.03
Variation Quotidienne
-0.08 -2.57%
Mensuellement
8.21%
Annuel
89.38%
Q1 Prévisions
2.89




Passifs Courants Changement Date
AbbVie USD 43.29B 3.9B 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Galectin Therapeutics USD 14.62M 1.98M 2024-06
Gilead Sciences USD 11.81B 485M 2025-12
Immunic USD 30.08M 2.77M 2025-09
Incyte USD 1.52B 176.44M 2025-12
Merck USD 28.63B 2.59B 2025-09